Epirubicin Induces Cell Cycle Arrest in Multiple Myeloma Cells by Downregulating CDC20 Expression
Epirubicin exerts anti-myeloma effects by downregulating CDC20 and inducing cell-cycle arrest in MM, highlighting CDC20 as a potential biomarker for identifying MM patients likely to benefit from epirubicin.
Authors
- Yushan Cui (ORCID: https://orcid.org/0000-0001-7619-7063)
- Xueting Wang (ORCID: https://orcid.org/0000-0002-1005-3072)
- Baijun Fang (ORCID: https://orcid.org/0000-0002-9087-8604)
- Yaomei Wang (ORCID: https://orcid.org/0009-0004-0234-965X)
- Zhen Nan (ORCID: https://orcid.org/0009-0003-0622-0346)
Institutions
- Henan Cancer Hospital (CN)
- Puyang Vocational and Technical College (CN)
Publication Details
- Journal
- Frontiers in Bioscience-Landmark
- Published
- 2025-11-26
- DOI
- https://doi.org/10.31083/fbl46326
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00